Main Page Winners Poland: Winners

Pharmaceutical products (№5593255)

16 jan

Number: 5593255

Country: Poland

Source: TED

PUSH for registration

Share:

Link to original

To view links to the source need to register

Publication date


16-01-2018

Description


  1. Section I
    1. Name and addresses
      Samodzielny Publiczny Zespół Opieki Zdrowotnej w Sanoku
      ul. 800-lecia 26
      Sanok
      38-500
      Poland
      Telephone: +48 134656290
      E-mail: [email protected]
      Fax: +48 134656290
    2. Type of the contracting authority:
      Body governed by public law
    3. Main activity:
      Health
  2. Section II
    1. Scope of the procurement:
      1. Title:

        Dostawa leków różnych do terapii WZW dla Spzoz w Sanoku.


        Reference number: SPZOZ/PN/43/2017
      2. Main CPV code:
        33600000, 33600000, 33600000, 33600000, 33600000, 33600000
      3. Type of contract:
        Supplies
      4. Short description:

        Przedmiotem zamówienia jest dostawa produktów leczniczych do terapii WZW typ C i B. Zaoferowane produkty muszą być dopuszczone (aktualnie) do obrotu na terenie Polski. Termin ważności oferowanego przedmiotu zamówienia nie może być krótszy niż 10 miesięcy od daty dostawy. Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu zamówienia-zał nr 2 do SIWZ.. Wykonawca musi zaoferować 60 dniowy termin płatności faktury VAT oraz okres niezmienności cen przez okres obowiązywania umowy. Zamawiający dopuszcza możliwość składania ofert równoważnych tj. równoważnych farmaceutyczne i terapeutycznie.- zgodnie z zapisami SIWZ.


      5. Information about lots:
        This contract is divided into lots: yes
      6. Total value of the procurement:
        Value excluding VAT: 876 388.00 PLN
    2. Description
      1. Title:

        Ladipasvirum, sofosbuvirum, ribavirynum


      2. Additional CPV code(s):
        33600000
      3. Place of performance:
      4. Description of the procurement:

        Zakup o charakterze sukcesywnym Ladipasvirum, sofosbuvirum, ribavirynum w 2 pozycjach asortymentowych.

        Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu.


      5. Award criteria:
        Quality criterion - Name: Termin Dostawy / Weighting: 40
        Price - Weighting: 60
      6. Information about options:
        Options: no
      7. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      8. Additional information:
      9. Title:

        Ombitasvir, paritaprevie, ritonavir, dezabuvir, ribavirin


      10. Additional CPV code(s):
        33600000
      11. Place of performance:
      12. Description of the procurement:

        Zakup o charakterze sukcesywnym Ombitasvir, paritaprevie, ritonavir, dezabuvir, ribavirin w 3 pozycjach asortymentowych.

        Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu zamówienia, cenowym stanowiącym załącznik nr 2 do Specyfikacji Istotnych Warunków Zamówienia.


      13. Award criteria:
        Quality criterion - Name: Termin Dostawy / Weighting: 40
        Price - Weighting: 60
      14. Information about options:
        Options: no
      15. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      16. Additional information:
      17. Title:

        Daclatssvir, Asunaprevir


      18. Additional CPV code(s):
        33600000
      19. Place of performance:
      20. Description of the procurement:

        Zakup o charakterze sukcesywnym Daclatssvir, Asunaprevir w 2 pozycjach asortymentowych.

        Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu zamówienia, cenowym stanowiącym załącznik nr 2 do Specyfikacji Istotnych Warunków Zamówienia.


      21. Award criteria:
        Quality criterion - Name: termin dostawy / Weighting: 40
        Price - Weighting: 60
      22. Information about options:
        Options: no
      23. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      24. Additional information:
      25. Title:

        Interferon alfa – 2a i rybaviryna


      26. Additional CPV code(s):
        33600000
      27. Place of performance:
      28. Description of the procurement:

        Zakup o charakterze sukcesywnym Interferon alfa – 2a i rybaviryna w 2 pozycjach asortymentowych.

        Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu zamówienia, cenowym stanowiącym załącznik nr 2 do Specyfikacji Istotnych Warunków Zamówienia.


      29. Award criteria:
        Quality criterion - Name: termin dostawy / Weighting: 40
        Price - Weighting: 60
      30. Information about options:
        Options: no
      31. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      32. Additional information:
      33. Title:

        Entekavir


      34. Additional CPV code(s):
        33600000
      35. Place of performance:
      36. Description of the procurement:

        Zakup o charakterze sukcesywnym Entekavir w 2 pozycjach asortymentowych.

        Szczegółowy opis, zakres i wielkość przedmiotu zamówienia został zawarty w formularzu przedmiotu zamówienia, cenowym stanowiącym załącznik nr 2 do Specyfikacji Istotnych Warunków Zamówienia.


      37. Award criteria:
        Quality criterion - Name: Termin Dostawy / Weighting: 40
        Price - Weighting: 60
      38. Information about options:
        Options: no
      39. Information about European Union funds:
        The procurement is related to a project and/or programme financed by European Union funds: no
      40. Additional information:
  3. Section IV
    1. Description:
      1. Type of procedure:
        Open procedure
      2. Information about a framework agreement or a dynamic purchasing system:
      3. Information about electronic auction:
      4. Information about the Government Procurement Agreement (GPA):
        The procurement is covered by the Government Procurement Agreement: no
    2. Administrative information:
      1. Previous publication concerning this procedure:
        Notice number in the OJ S: 2017/S 210-435694
      2. Information about termination of dynamic purchasing system:
      3. Information about termination of call for competition in the form of a prior information notice:
  4. Section V
    1. Lot No: 1
      Title:

      Ladipasvirum, sofosbuvirum, ribavirynum


    2. Award of contract
      1. Date of conclusion of the contract: 2017-12-14
      2. Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        Number of tenders received by electronic means: 0
        The contract has been awarded to a group of economic operators: yes
      3. Name and address of the contractor:
        Konsorcjum: PGF Urtica Sp. z o.o., PGF S.A.
        ul. Krzemieniecka 120
        Wrocław
        54-613
        Poland
        Telephone: +48 717826601
        Fax: +48 717826643
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):
        Initial estimated total value of the contract/lot: 421 766.64 PLN
        Total value of the contract/lot: 421 767.52 PLN
      5. Information about subcontracting:

        Lot No: 2
        Title:

        Ombitasvir, paritaprevie, ritonavir, dezabuvir, ribavirin


      6. Award of contract
        1. Date of conclusion of the contract: 2017-12-14
        2. Information about tenders:
          Number of tenders received: 1
          Number of tenders received from SMEs: 0
          Number of tenders received from tenderers from other EU Member States: 0
          Number of tenders received from tenderers from non-EU Member States: 0
          Number of tenders received by electronic means: 0
          The contract has been awarded to a group of economic operators: no
        3. Name and address of the contractor:
          Abbvie Sp. z o.o.
          ul.Postępu 21 B
          Warszawa
          02-676
          Poland
          Telephone: +48 223727870
          Fax: +48 223727809
          The contractor is an SME: no
        4. Information on value of the contract/lot (excluding VAT):
          Initial estimated total value of the contract/lot: 361 140.90 PLN
          Total value of the contract/lot: 361 140.90 PLN
        5. Information about subcontracting:

          Contract No: 3
          Title:

          Daclatssvir, Asunaprevir


        6. Award of contract
          1. Date of conclusion of the contract: 2017-12-14
          2. Information about tenders:
            Number of tenders received: 1
            Number of tenders received from SMEs: 0
            Number of tenders received from tenderers from other EU Member States: 0
            Number of tenders received from tenderers from non-EU Member States: 0
            Number of tenders received by electronic means: 0
            The contract has been awarded to a group of economic operators: yes
          3. Name and address of the contractor:
            Konsorcjum PGF Urtica Sp. z o.o.
            ul. Krzemieniecka 120
            Wrocław
            54-613
            Poland
            Telephone: +48 717826601
            Fax: +48 717826643
            The contractor is an SME: no
          4. Information on value of the contract/lot (excluding VAT):
            Initial estimated total value of the contract/lot: 48 172.08 PLN
            Total value of the contract/lot: 48 172.08 PLN
          5. Information about subcontracting:

            Lot No: 4
            Title:

            Interferon alfa – 2a i rybaviryna


          6. Award of contract
            1. Date of conclusion of the contract: 2017-12-29
            2. Information about tenders:
              Number of tenders received: 1
              Number of tenders received from SMEs: 0
              Number of tenders received from tenderers from other EU Member States: 0
              Number of tenders received from tenderers from non-EU Member States: 0
              Number of tenders received by electronic means: 0
              The contract has been awarded to a group of economic operators: no
            3. Name and address of the contractor:
              Roche Polska Sp. z o.o.
              ul. Domaniewska 39B
              Warszawa
              02-672
              Poland
              Telephone: +48 222605161
              Fax: +48 223451527
              The contractor is an SME: no
            4. Information on value of the contract/lot (excluding VAT):
              Initial estimated total value of the contract/lot: 40 502.10 PLN
              Total value of the contract/lot: 40 178.10 PLN
            5. Information about subcontracting:

              Lot No: 5
              Title:

              Entekavir


            6. Award of contract
              1. Date of conclusion of the contract: 2017-12-29
              2. Information about tenders:
                Number of tenders received: 3
                Number of tenders received from SMEs: 1
                Number of tenders received from tenderers from other EU Member States: 0
                Number of tenders received from tenderers from non-EU Member States: 0
                Number of tenders received by electronic means: 0
                The contract has been awarded to a group of economic operators: no
              3. Name and address of the contractor:
                Asclepios S.A.
                ul. Hubska 44
                Wrocław
                50-502
                Poland
                Telephone: +48 717698410
                Fax: +48 717215625
                The contractor is an SME: yes
              4. Information on value of the contract/lot (excluding VAT):
                Initial estimated total value of the contract/lot: 18 106.50 PLN
                Total value of the contract/lot: 5 129.40 PLN
              5. Information about subcontracting:

          7. Section VI
            1. Additional information
            2. Procedures for review
              1. Review body
                Prezes Krajowej Izby Odwoławczej
                ul. Postępu 17A
                Warszawa
                02-676
                Poland
                Telephone: +48 224587801
                E-mail: [email protected]
                Fax: +48 224587800
              2. Body responsible for mediation procedures

              3. Service from which information about the review procedure may be obtained
                Urząd Zamówień Publicznych
                ul. Postępu 17A
                Warszawa
                02-676
                Poland
            3. Date of dispatch of this notice
              2018-01-12